213 related articles for article (PubMed ID: 29607554)
1. Anti-inflammatory potency testing of topical corticosteroids and calcineurin inhibitors in human volunteers sensitized to diphenylcyclopropenone.
Mose KF; Andersen F; Røpke MA; Skov L; Friedmann PS; Andersen KE
Br J Clin Pharmacol; 2018 Aug; 84(8):1719-1728. PubMed ID: 29607554
[TBL] [Abstract][Full Text] [Related]
2. Parallel intraindividual evaluation of the vasoconstrictory action and the anti-allergic activity of topical corticosteroids.
Seidenari S; Di Nardo A; Mantovani L; Giannetti A
Exp Dermatol; 1997 Apr; 6(2):75-80. PubMed ID: 9209888
[TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus for atopic dermatitis.
Cury Martins J; Martins C; Aoki V; Gois AF; Ishii HA; da Silva EM
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009864. PubMed ID: 26132597
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of activity of different topical corticosteroid creams and ointments using a vasoconstriction assay: superiority of hydrocortisone butyrate over hydrocortisone].
Korting HC; Maslen K; Gross G; Willers C
J Dtsch Dermatol Ges; 2005 May; 3(5):348-53. PubMed ID: 16372801
[TBL] [Abstract][Full Text] [Related]
5. The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies.
Gibson JR; Darley C; Kirsch J; Saihan EM; Neild VS
Br J Dermatol; 1982 Apr; 106(4):445-7. PubMed ID: 7073968
[TBL] [Abstract][Full Text] [Related]
6. A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis.
Bhardwaj SS; Jaimes JP; Liu A; Warshaw EM
Dermatitis; 2007 Mar; 18(1):26-31. PubMed ID: 17303041
[TBL] [Abstract][Full Text] [Related]
7. Comparison of reservoir effect of topical corticosteroids in an experimental animal model by histamine-induced wheal suppression test.
Abidi A; Ahmad F; Singh SK; Kumar A
Indian J Pharmacol; 2012; 44(6):722-5. PubMed ID: 23248401
[TBL] [Abstract][Full Text] [Related]
8. The effect of tacrolimus compared with betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis.
Danby SG; Chittock J; Brown K; Albenali LH; Cork MJ
Br J Dermatol; 2014 Apr; 170(4):914-21. PubMed ID: 24328907
[TBL] [Abstract][Full Text] [Related]
9. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
[TBL] [Abstract][Full Text] [Related]
10. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT.
Guichard A; Humbert P; Tissot M; Muret P; Courderot-Masuyer C; Viennet C
Int J Pharm; 2015 Feb; 479(2):422-9. PubMed ID: 25556056
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of topical calcineurin inhibitors in vitiligo.
Wong R; Lin AN
Int J Dermatol; 2013 Apr; 52(4):491-6. PubMed ID: 23331250
[TBL] [Abstract][Full Text] [Related]
12. The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.
Queille-Roussel C; Paul C; Duteil L; Lefebvre MC; Rapatz G; Zagula M; Ortonne JP
Br J Dermatol; 2001 Mar; 144(3):507-13. PubMed ID: 11260007
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis.
Saripalli YV; Gadzia JE; Belsito DV
J Am Acad Dermatol; 2003 Sep; 49(3):477-82. PubMed ID: 12963912
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
Ashcroft DM; Dimmock P; Garside R; Stein K; Williams HC
BMJ; 2005 Mar; 330(7490):516. PubMed ID: 15731121
[TBL] [Abstract][Full Text] [Related]
15. Topical glucocorticoids of the non-fluorinated double-ester type. Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound.
Kerscher MJ; Korting HC
Acta Derm Venereol; 1992; 72(3):214-6. PubMed ID: 1357864
[TBL] [Abstract][Full Text] [Related]
16. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation.
Oussedik E; Saleem MD; Feldman SR
J Drugs Dermatol; 2017 Oct; 16(10):972-975. PubMed ID: 29036250
[TBL] [Abstract][Full Text] [Related]
18. Vasoconstrictor potency of fixed-dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam versus other topical corticosteroids used to treat psoriasis vulgaris.
Queille-Roussel C; Nielsen J; Lacour JP
J Dermatolog Treat; 2019 Sep; 30(6):529-533. PubMed ID: 30582717
[No Abstract] [Full Text] [Related]
19. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis.
Bhol KC; Schechter PJ
Br J Dermatol; 2005 Jun; 152(6):1235-42. PubMed ID: 15948987
[TBL] [Abstract][Full Text] [Related]
20. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
Serup J; Holm P
Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
